Omeprazol Sandoz (Omeprazole)

Omeprazol Sandoz is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions:

• Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.
• NSAID‑induced gastropathy: helps prevent ulcer formation in patients requiring long‑term NSAID therapy.

• Omeprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly reduces both basal and stimulated gastric acid secretion, allowing the gastric mucosa to heal and maintain a higher pH environment.

Omeprazol Sandoz may cause a range of adverse reactions. Most are mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: watery stools without blood.
• Nausea: occasional upset stomach.
• Abdominal pain: cramping or discomfort.
• Flatulence: increased gas production.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
• Hypomagnesemia: low serum magnesium causing muscle cramps or arrhythmias.
• Acute interstitial nephritis: kidney inflammation with reduced urine output.
• Stevens‑Johnson syndrome: severe skin reaction with blistering.
• Liver enzyme elevation: increased ALT/AST levels indicating hepatic stress.
• Fracture risk: potential reduction in bone mineral density with long‑term use.

Before starting Omeprazol Sandoz, consider the following safety measures:

• Assess renal function: dose adjustment may be needed in severe impairment.
• Review hepatic status: use with caution in moderate liver disease.
• Evaluate for infections: monitor for Clostridioides difficile if prolonged therapy is planned.
• Consider bone health: assess fracture risk for patients on long‑term therapy.
• Pregnancy and lactation: discuss potential risks with a healthcare professional.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazol Sandoz can affect the pharmacokinetics of several co‑administered medicines. Interaction management is essential.

Major Interactions (Avoid)

• Ketamine: increased plasma concentration leading to heightened sedation.
• Clopidogrel: reduced antiplatelet effect, potentially lowering cardiovascular protection.
• Atazanavir: decreased absorption due to higher gastric pH.

Moderate Interactions (Monitor Closely)

• Warfarin: possible alteration of INR values; monitor coagulation.
• Digoxin: modest increase in serum levels; observe for toxicity.
• Methotrexate: reduced renal clearance may raise systemic exposure.